The associations between these conditions and insomnia are corroborated by endocrinological studies reporting that growth hormone therapy is increasingly being used in heart disease treatment [66], as it enhances blood flow and some neurotrophic factors [67] by inducing T cell production [68,69]; this suggests that there is a functional deficiency of this hormone in heart diseases. Here, GH1 is linked to insomnia measurement.